Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-26 @ 3:19 PM
NCT ID:
NCT07432594
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years.
* Histologically confirmed high-grade serous ovarian cancer (HGSC), fallopian tube cancer, or primary peritoneal cancer.
* International Federation of Gynecology and Obstetrics (FIGO) stage IIIC-IV.
* Eastern Cooperative Oncology Group (ECOG) performance status of 0-1.
* Assessed by a multidisciplinary team (MDT) based on imaging (± laparoscopic exploration) as initially unable to achieve satisfactory tumor debulking (R0 resection).
* At least one measurable lesion according to Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1 criteria.
* Major organ function is basically normal.
* Willing to provide tumor tissue, peripheral blood, and ascites samples for translational research.
Exclusion Criteria:
* Pathological types other than high-grade serous carcinoma (HGSC).
* Prior receipt of any form of anti-tumor therapy.
* History of autoimmune disease or requiring immunosuppressive therapy.
* Known allergy to study drug components.
* Pregnant or lactating women.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT07432594
Study Brief:
Protocol Section:
NCT07432594